Hepatic inflammatory responses to αα-cross-linked hemoglobin infusion in rats

Journal of Laboratory and Clinical Medicine

Volumn 131, Issue 5, 1998, Pages 432-441

  Przybocki, Joan M ^a   Mccalden, Thomas A ^a   Collier, John M ^a   Billings, Ruth E ^a  

^a Department of Ecosystem Science and Sustainability   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032078273     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90144-5     Document Type: Article

References (54)

1. Ogden JE, Parry ES. The development of hemoglobin solutions as red cell substitutes. Int Anesthesiol Clin 1995;33:115-29.
2. Winslow RM. Potential clinical applications for blood substitutes. Biomater Artif Cells Immobil Biotechnol 1992;20:205-17.
3. Farley D. Alternatives to regular blood transfusions. FDA Consumer 1994;28:5-9.
4. Joyner MJ, Faust RJ. Blood substitutes: what is the target? In: Winslow RM, Vandegriff KD, Intaglietta M, editors. Blood substitutes: new challenges. Boston: Birkhauser, 1996:15-33.
5. Snyder SR, Welty EV, Walder RY, Williams LA, Walder JA. HbXL99 alpha: a hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute. Proc Natl Acad Sci U S A 1987;84:7280-4.
6. Manning LR, Morgan S, Beavis RC, et al. Preparation, properties, and plasma retention of human hemoglobin derivatives: comparison of uncross-linked carboxymethylated hemoglobin with cross-linked tetrameric hemoglobin. Proc Natl Acad Sci U S A 1991;88:3329-33.
7. Bunn HF. The use of hemoglobin as a blood substitute. Am J Hematol 1993;42:112-7.
8. Sharma AC, Rebello S, Gulati A. Regional circulatory and systemic hemodynamic effects of diaspirin cross-linked hemoglobin in the rat. Artif Cells Blood Substit Immobil Biotechnol 1994;22:593-602.
9. Malcolm DS, Hamilton IN, Schultz SC, Cole F, Burhop KE. Characterization of the hemodynamic response to intravenous diaspirin cross-linked hemoglobin solutions in rats. Artif Cells Blood Substit Immobil Biotechnol 1994;22:91-107.
10. Greenburg AG, Kim HW. Use of donor blood in the surgical setting: potentials for application of blood substitutes. Artif Cells Blood Substit Immobil Biotechnol 1997;25:25-9.
11. Hess JR. Review of modified hemoglobin research at Letterman: attempts to delineate the toxicity of cell-free tetrameric hemoglobin. Artif Cells Blood Substit Immobil Biotechnol 1995;23:277-89.
12. Sanders KE, Ackers G, Sligar S. Engineering and design of blood substitutes. Curr Opin Struct Biol 1996;6:534-40.
13. Everse J, Hsia N. The toxicities of native and modified hemoglobins. Free Radic Biol Med 1997;22:1075-99.
14. Smith CD, Schuschereba ST, Hess JR, McKinney L, Bunch D, Bowman PD. Liver and kidney injury after administration of hemoglobin cross-linked with bis(3,5-dibromosalicyl) fumarate. Biomater Artif Cells Immobil Biotechnol 1990;18:251-61.
15. Hsia N, Everse J. The cytotoxic activities of human hemoglobin and diaspirin cross-linked hemoglobin. Artif Cells Blood Substit Immobil Biotechnol 1996;24:533-51.
16. Maines MD, Trakshel GM. Differential regulation of heme oxygenase isozymes by Sn- and Zn-protoporphyrins: possible relevance to suppression of hyperbilirubinemia. Biochim Biophys Acta 1992;1131:166-74.
17. Halliwell B, Gutteridge JM. Oxygen radicals, transition metals and disease. Biochem J 1984;219:1-14.
18. Takami M. Catabolism of heme moiety of hemoglobin haptoglobin in rat liver cells in vivo. J Biol Chem 1993;268:20335-42.
19. Laskin DL. Nonparenchymal cells and hepatotoxicity. Semin Liver Dis 1990;10:293-304.
20. Nathan CF. Secretory products of macrophages. J Clin Invest 1987;79:319-26.
21. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990;192:245-61.
22. Liu P, McGuire GM, Fisher MA, Farhood A, Smith CW, Jaeschke H. Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxin-enhanced liver injury after hepatic ischemia. Shock 1995;3:56-62.
23. Balla G, Vercellotti GM, Muller-Eberhard U, Eaton J, Jacob HS. Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest 1991;64:648-55.
24. Jaeschke H. Mechanisms of oxidant stress-induced acute tissue injury. Proc Soc Exp Biol Med 1995;209:104-11.
25. Celada A, Nathan CF. Macrophage activation revisted. Immunol Today 1994;15:100-2.
26. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990;4:3355-9.
27. Maloney WC, McPherson K, Fliegelman L. Esterase activity in leukocytes demonstrated by the use of naphthol AS-D chloroacetate substrate. J Histochem Cytochem 1960;8:200-7.
28. Maines MD, Trakshel GM, Kutty RK. Characterization of two constitutive forms of rat liver microsomal heme oxygenase. J Biol Chem 1986;261:411-9.
29. Shibahara S, Muller R, Taguchi H, Yoshida T. Cloning and expression for rat heme oxygenase. Proc Natl Acad Sci U S A 1985;82:7865-9.
30. Ku RH, Billings RE. The role of mitochondrial glutathione and cellular protein sulfhydryls in formaldehyde toxicity in glutathione depleted rat hepatocytes. Arch Biochem Biophys 1986;247:183-9.
31. Kutty RK, Maines MD. Purification and characterization of biliverdin reductase from rat liver. J Biol Chem 1981;-256:3956-62.
32. Tenhunen R, Marver HS, Schmid R. Microsomal heme oxygenase. J Biol Chem 1969;244:6388-94.
33. Maines MD, Kappas A. Cobalt stimulation of heme degradation in the liver. J Biol Chem 1975;250:4171-7.
34. Hattori M, Tugores A, Veloz L, Karin M, Brenner DA. Laboratory methods: a simplified method for the preparation of transcriptionally active liver nuclear extracts. DNA Cell Biol 1990;9:777-81.
35. Duval DL, Miller DR, Collier J, Billings RE. Characterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants. Mol Pharmacol 1996;50:1-8.
36. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;-150:76-85.
37. Sheehan KCF, Ruddle NH, Schreiber RD. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol 1989;-142:3884-93.
38. Burhop KE, Farrell L, Nigro C, Tan D, Estep T. Effects of intravenous infusions of diaspirin cross-linked hemoglobin (DCLHb) on sheep. Biomater Artif Cells Immobil Biotechnol 1992;20:581-5.
39. Bush S, Marshall T, Spicuzza J, Nelson D. Diaspirin cross-linked hemoglobin (DCLHb™): bioanalytical studies in swine. Artif Cells Blood Substit Immobil Biotechnol 1994;22:917-22.
40. Estep T, Gonder J, Bornstein I, Aono F. Immunogenicitiy of diaspirin cross-linked human hemoglobin solutions. Biomater Artif Cells Immobil Biotechnol 1992;20:603-9.
41. McFaul SJ, Bowman PD, Villa VM, Gutierrez-Ibanez MJ, Johnson M, Smith D. Hemoglobin stimulates mononuclear leukocytes to release interleukin-8 and tumor necrosis factor α. Blood 1994;9:3175-81.
42. Larrick JW, Kunkel SL. The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response. Pharm Res 1988;5:129-39.
43. Baeuerle PA, Baltimore D. The physiology of the NF-κB transcription factor. In: Cohen P, Foulkes JG, editors. Hormonal control regulation of gene expression. Amsterdam: Biomedical Press Elsevier, 1991:409-32.
44. Goldring C, Narayana R, Lagadec P, Jeannin J. Transcriptional inhibition of the inducible nitric oxide synthase gene by competitive binding of NF-κB /Rel protein. Biochem Biophys Res Commun 1995;209:73-9.
45. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription and HIV-1. EMBO J 1991;10:2247-58.
46. Schreck R, Baeuerle PA. Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-κB. Methods Enzymol 1994;234:151-63.
47. Larrick JW, Wright SC. Cytotoxic mechanism of tumor necrosis factor-α. FASEB J 1990;4:3215-23.
48. Duval DL, Sieg DJ, Billings RE. Regulation of hepatic nitric oxide synthase by reactive oxygen intermediates and glutathione. Arch Biochem Biophys 1994;316:699-706.
49. Balla G, Jacob HS, Balla J, et al. Ferritin: a cytoprotective antioxidant stratagem of endothelium. J Biol Chem 1992;267:18148-53.
50. Sardana MK, Sassa S, Kappas A. Metal ion-mediated regulation of heme oxygenase induction in cultured avian liver cells. J Biol Chem 1982;257:4806-11.
51. Applegate LA, Luscher P, Tyrrell RM. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res 1991;51:974-8.
52. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Biochem J 1987;290:343-7.
53. Stocker R. Induction of haem oxygenase as a defence against oxidative stress. Free Radic Res Commun 1990;9:101-12.
54. Otterbein L, Sylvester SL, Choi AMK. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am J Respir Cell Mol Biol 1995;13:595-601.